Closed · PAR-08-155 · CFDA 93.279;93.282;93.865;93.989 · Discretionary
PHASE II Comprehensive ICOHRTA AIDS/TB (U2R)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $275K
- Award range
- Closed
- Status
- August 18, 2009
- Close date
- -
- Expected awards
The verdict
PHASE II Comprehensive ICOHRTA AIDS/TB (U2R) is a closed discretionary listing from National Institutes of Health that offered Up to $275,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.
- up to $275K
- award range
- Closed
- application status
- 93.279;93.282;93.865;93.989
- CFDA program
- 12,419
- other opportunities from National Institutes of Health
Archived opportunity record
PHASE II Comprehensive ICOHRTA AIDS/TB (U2R) is closed (last close August 18, 2009). Check the agency catalog for replacement NOFOs. National Institutes of Health still indexes 12,419 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed August 18, 2009
Est. Total Funding
$3,000,000
Instrument
Cooperative Agreement
Description
-Purpose. This Funding Opportunity Announcement (FOA), PAR-08-155, issued by FIC, NIMH, ORWH, and NIDA, NIH solicits renewal (re-competing) and new Phase II applications in the International Clinical, Operations and Health Services Research Training Award for AIDS and TB (ICOHRTA AIDS TB) program. The applications from a Research Training Unit , composed of a Phase I ICOHRTA AIDS TB (planning grant) recipient and the U.S. partner institution chosen by the Phase I recipient, must propose, in an integrated manner, a comprehensive training program that will strengthen the capacity in the foreign country to conduct clinical research and implementation science, including operations and health services research focused on HIV infection, TB, and, where relevant, HIV/TB co-infection prevention, care and treatment. -Mechanism of Support. This FOA will utilize the International Training Cooperative Agreement (U2R) grant mechanism -Funds Available and Anticipated Number of Awards The estimated amount of funds available for support of five-six new or renewal Research Training Units awarded as a result of this announcement is $3,000,000 for fiscal year 2009. Future year amounts will depend on annual appropriations. Facilities and administrative costs are limited to 8% for all awards and sub-awards. The earliest anticipated start dates for awards are April 1, 2009.
Campus–civic applicant bridge · 5 doors
PHASE II Comprehensive ICOHRTA AIDS/TB (U2R) bridges educational institutions with civic applicant types (5 doors: Public / state-controlled institutions of higher education; Nonprofits with 501(c)(3) status (other than IHEs); Nonprofits without 501(c)(3) status (other than IHEs); Private institutions of higher education; +1 more). Expect campus and public/nonprofit operators in the same printed set. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Education · Health · Income Security and Social Services (ED;HL;ISS). Only 197 other National Institutes of Health listings share this exact eligibility-code string (2% of 12,420).
- Code 06
- Public / state-controlled institutions of higher education
- Code 12
- Nonprofits with 501(c)(3) status (other than IHEs)
- Code 13
- Nonprofits without 501(c)(3) status (other than IHEs)
- Code 20
- Private institutions of higher education
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
What to do next
PHASE II Comprehensive ICOHRTA AIDS/TB (U2R) is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.279;93.282;93.865;93.989 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |